Skip to main content

Advertisement

Log in

Liver Resection for Multimodal Treatment of Breast Cancer Metastases: Identification of Prognostic Factors

  • Breast Oncology
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

Abstract

Background

Liver resection (LR) within a multimodal treatment concept of hepatic metastases (HM) that results from breast cancer has been controversially discussed. The aim of this study was to evaluate the outcome of LR in patients with hepatic breast cancer metastases.

Methods

Prospectively collected data from 41 consecutive patients who underwent LR for HM between 1999 and 2008 were analyzed retrospectively. Univariate and multivariate analyses were performed to assess potential prognostic factors.

Results

Segmental resection was performed in 46% and major hepatectomy in 54% of patients. The postoperative mortality rate was 0%. At a median follow-up of 34 months, 26 patients were alive. The median and 5-year overall survival rates after LR were 58 months and 48%, respectively. The median and 5-year disease-free survivals were 34 months and 31%, respectively. The intrahepatic recurrence-free 5-year survival was 62%. The median survival from time of diagnosis of HM was 79 months. The positive resection margin as well as a disease-free interval between the treatment of the primary tumor and the diagnosis of HM < 1 year were independent predictors of overall survival.

Conclusions

LR of hepatic breast cancer metastases within a multimodal treatment concept is a safe procedure in well-selected patients. Both a short time interval to the development of HM and positive resection margins after LR are strongly associated with worse long-term survival.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Ferlay J, Bray F, Pisani P, Parkin DM. GLOBOCAN 2002. Cancer incidence, mortality and prevalence worldwide. IARC Cancer Base No. 5. Version 2.0. Lyon, France: IARC Press, 2004.

  2. Fisher B, Anderson S, Bryant J, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med. 2002;347:1233–41.

    Article  PubMed  Google Scholar 

  3. Fisher B, Jeong JH, Anderson S, et al. Twenty-five-year follow-up of a randomized trial comparing radical mastectomy, total mastectomy, and total mastectomy followed by irradiation. N Engl J Med. 2002;347:567–75.

    Article  PubMed  Google Scholar 

  4. Jardines L, Callans LS, Torosian MH. Recurrent breast cancer: presentation, diagnosis, and treatment. Semin Oncol. 1993;20:538–47.

    CAS  PubMed  Google Scholar 

  5. Insa A, Lluch A, Prosper F, et al. Prognostic factors predicting survival from first recurrence in patients with metastatic breast cancer: analysis of 439 patients. Breast Cancer Res Treat. 1999;56:67–78.

    Article  CAS  PubMed  Google Scholar 

  6. Eichbaum MH, Kaltwasser M, Bruckner T, et al. Prognostic factors for patients with liver metastases from breast cancer. Breast Cancer Res. Treat. 2006;96:53–62.

    Article  PubMed  Google Scholar 

  7. Fong Y, Salo J. Surgical therapy of hepatic colorectal metastasis. Semin Oncol. 1999;26:514–23.

    CAS  PubMed  Google Scholar 

  8. Fuhrman GM, Curley SA, Hohn DC, Roh MS. Improved survival after resection of colorectal liver metastases. Ann Surg Oncol. 1995;2:537–41.

    Article  CAS  PubMed  Google Scholar 

  9. Seifert JK, Weigel TF, Gonner U, Bottger TC, Junginger T. Liver resection for breast cancer metastases. Hepatogastroenterology. 1999;46:2935–40.

    CAS  PubMed  Google Scholar 

  10. Vlastos G, Smith DL, Singletary SE, et al. Long-term survival after an aggressive surgical approach in patients with breast cancer hepatic metastases. Ann Surg Oncol. 2004;11:869–74.

    Article  PubMed  Google Scholar 

  11. Yoshimoto M, Tada T, Saito M, et al. Surgical treatment of hepatic metastases from breast cancer. Breast Cancer Res Treat. 2000;59:177–84.

    Article  CAS  PubMed  Google Scholar 

  12. Pocard M, Pouillart P, Asselain B, Salmon R. Hepatic resection in metastatic breast cancer: results and prognostic factors. Eur J Surg Oncol. 2000;26:155–9.

    Article  CAS  PubMed  Google Scholar 

  13. Elias D, Maisonnette F, Druet-Cabanac M, et al. An attempt to clarify indications for hepatectomy for liver metastases from breast cancer. Am J Surg. 2003;185:158–64.

    Article  PubMed  Google Scholar 

  14. Adam R, Aloia T, Krissat J, et al. Is liver resection justified for patients with hepatic metastases from breast cancer? Ann Surg. 2006;244:897–907.

    Article  PubMed  Google Scholar 

  15. Poon RT, Fan ST, Lo CM, et al. Improving perioperative outcome expands the role of hepatectomy in management of benign and malignant hepatobiliary diseases: analysis of 1222 consecutive patients from a prospective database. Ann Surg. 2004;240:698–708.

    PubMed  Google Scholar 

  16. Jarnagin WR, Gonen M, Fong Y, et al. Improvement in perioperative outcome after hepatic resection: analysis of 1,803 consecutive cases over the past decade. Ann Surg. 2002;236:397–406.

    Article  PubMed  Google Scholar 

  17. Schemmer P, Friess H, Hinz U, et al. Stapler hepatectomy is a safe dissection technique: analysis of 300 patients. World J Surg. 2006;30:419–30.

    Article  PubMed  Google Scholar 

  18. Sakamoto Y, Yamamoto J, Yoshimoto M, et al. Hepatic resection for metastatic breast cancer: prognostic analysis of 34 patients. World J Surg. 2005;29:524–7.

    Article  PubMed  Google Scholar 

  19. Sobin LH, Wittekind CH. TNM classification of malignant tumours. 6th ed. New York: Wiley Liss, 2002.

    Google Scholar 

  20. Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240:205–13.

    Article  PubMed  Google Scholar 

  21. Goldhirsch A, Gelber RD, Castiglione M. Relapse of breast cancer after adjuvant treatment in premenopausal and perimenopausal women: patterns and prognoses. J Clin Oncol. 1988;6:89–97.

    CAS  PubMed  Google Scholar 

  22. Kiang DT, Kennedy BJ, Younger J, et al. Alternating chemotherapy regimens for patients with metastatic breast cancer. A pilot study based on tumor marker kinetics. Cancer and Leukemia Group B. Cancer. 1995;75:826–30.

    Article  CAS  PubMed  Google Scholar 

  23. Piccart MJ, Raymond E, Aapro M, Eisenhauer EA, Cvitkovic E. Cytotoxic agents with activity in breast cancer patients previously exposed to anthracyclines: current status and future prospects. Eur J Cancer. 1995;31A(Suppl 7):S1–10.

    Article  CAS  PubMed  Google Scholar 

  24. O’Reilly SM, Richards MA, Rubens RD. Liver metastases from breast cancer: the relationship between clinical, biochemical and pathological features and survival. Eur J Cancer. 1990;26:574–7.

    Article  PubMed  Google Scholar 

  25. Wyld L, Gutteridge E, Pinder SE, et al. Prognostic factors for patients with hepatic metastases from breast cancer. Br J Cancer. 2003;89:284–90.

    Article  CAS  PubMed  Google Scholar 

  26. Kondo S, Katoh H, Omi M, et al. Hepatectomy for metastases from breast cancer offers the survival benefit similar to that in hepatic metastases from colorectal cancer. Hepatogastroenterology. 2000;47:1501–3.

    CAS  PubMed  Google Scholar 

  27. Maksan SM, Lehnert T, Bastert G, Herfarth C. Curative liver resection for metastatic breast cancer. Eur. J. Surg. Oncol. 2000;26:209–12.

    Article  CAS  PubMed  Google Scholar 

  28. Selzner M, Morse MA, Vredenburgh JJ, Meyers WC, Clavien PA. Liver metastases from breast cancer: long-term survival after curative resection. Surgery. 2000;127:383–9.

    Article  CAS  PubMed  Google Scholar 

  29. Carlini M, Lonardo MT, Carboni F, et al. Liver metastases from breast cancer. Results of surgical resection. Hepatogastroenterology. 2002;49:1597–601.

    PubMed  Google Scholar 

  30. Ercolani G, Grazi GL, Ravaioli M, et al. The role of liver resections for noncolorectal, nonneuroendocrine metastases: experience with 142 observed cases. Ann. Surg. Oncol. 2005;12:459–66.

    Article  PubMed  Google Scholar 

  31. Furka A, Halasz L, Szentkereszty Z, et al. Surgical treatment of liver metastases from breast cancer. Hepatogastroenterology. 2008;55:1416–8.

    CAS  PubMed  Google Scholar 

  32. Kollmar O, Moussavian MR, Richter S, Bolli M, Schilling MK. Surgery of liver metastasis in gynecological cancer—indication and results. Onkologie. 2008;31:375–9.

    Article  PubMed  Google Scholar 

  33. d’Annibale M, Piovanello P, Cerasoli V, Campioni N. Liver metastases from breast cancer: the role of surgical treatment. Hepatogastroenterology. 2005;52:1858–62.

    PubMed  Google Scholar 

  34. Thelen A, Benckert C, Jonas S, et al. Liver resection for metastases from breast cancer. J Surg Oncol. 2008;97:25–9.

    Article  PubMed  Google Scholar 

  35. Krag DN, Ashikaga T, Moss TJ, et al. Breast cancer cells in the blood: a pilot study. Breast J. 1999;5:354–8.

    Article  PubMed  Google Scholar 

  36. Beitsch PD, Clifford E. Detection of carcinoma cells in the blood of breast cancer patients. Am J Surg. 2000;180:446–8.

    Article  CAS  PubMed  Google Scholar 

  37. Raab R, Nussbaum KT, Behrend M, Weimann A. Liver metastases of breast cancer: results of liver resection. Anticancer Res. 1998;18(3C):2231–3.

    CAS  PubMed  Google Scholar 

  38. Lubrano J, Roman H, Tarrab S, et al. Liver resection for breast cancer metastasis: does it improve survival? Surg Today. 2008;38:293–9.

    Article  PubMed  Google Scholar 

  39. Caralt M, Bilbao I, Cortes J, et al. Hepatic resection for liver metastases as part of the “oncosurgical” treatment of metastatic breast cancer. Ann. Surg. Oncol. 2008;15:2804–10.

    Article  PubMed  Google Scholar 

Download references

Acknowledgment

We thank Heather Karner for language edition of the manuscript and L. Mikalauskiene, S. Mikalauskas, R. Liang, X. Li , M. Manikas and A. Cekauskas for collecting the tissue samples.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Peter Schemmer MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hoffmann, K., Franz, C., Hinz, U. et al. Liver Resection for Multimodal Treatment of Breast Cancer Metastases: Identification of Prognostic Factors. Ann Surg Oncol 17, 1546–1554 (2010). https://doi.org/10.1245/s10434-010-0931-5

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-010-0931-5

Keywords

Navigation